Abstract
The production of high-affinity protective antibodies requires somatic hypermutation (SHM) of the antibody variable (V)-region genes. SHM is characterized by a high frequency of point mutations that occur only during the centroblast stage of B-cell differentiation. Activation-induced cytidine deaminase (AID), which is expressed specifically in germinal-centre centroblasts1, is required for this process, but its exact role is unknown2. Here we show that AID is required for SHM in the centroblast-like Ramos cells, and that expression of AID is sufficient to induce SHM in hybridoma cells, which represent a later stage of B-cell differentiation that does not normally undergo SHM. In one hybridoma, mutations were exclusively in G·C base pairs that were mostly within RGYW or WRCY motifs, suggesting that AID has primary responsibility for mutations at these nucleotides. The activation of SHM in hybridomas indicates that AID does not require other centroblast-specific cofactors to induce SHM, suggesting either that it functions alone or that the factors it requires are expressed at other stages of B-cell differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal centre B cells. J. Biol. Chem. 274, 18470–18476 (1999)
Kinoshita, K. & Honjo, T. Linking class-switch recombination with somatic hypermutation. Nature Rev. Mol. Cell Biol. 2, 493–503 (2001)
Sale, J. E. & Neuberger, M. S. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9, 859–869 (1998)
Denépoux, S. et al. Induction of somatic mutation in a human B cell line in vitro. Immunity 6, 35–46 (1997)
Zan, H. et al. Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.. J. Immunol. 162, 3437–3447 (1999)
Zhang, W. et al. Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int. Immunol. 13, 1175–1184 (2001)
Wagner, S. D., Milstein, C. & Neuberger, M. S. Codon bias targets mutation. Nature 376, 732 (1995)
Rogozin, I. B. & Kolchanov, N. A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171, 11–18 (1992)
Connor, A., Wiersma, E. & Shulman, M. J. On the linkage between RNA processing and RNA translatability. J. Biol. Chem. 269, 25178–25184 (1994)
Lin, M. M., Zhu, M. & Scharff, M. D. Sequence dependent hypermutation of the immunoglobulin heavy chain in cultured B cells. Proc. Natl Acad. Sci. USA 94, 5284–5289 (1997)
Luria, S. E. & Delbruck, M. Mutation of bacteria from virus sensitivity to virus resistance. Genetics 28, 491–511 (1943)
Rada, C. & Milstein, C. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J. 20, 4570–4576 (2001)
Rada, C., Yelamos, J., Dean, W. & Milstein, C. The 5′ hypermutation boundary of κ chains is independent of local and neighbouring sequences and related to the distance from the initiation of transcription. Eur. J. Immunol. 27, 3115–3120 (1997)
Tao, W. & Bothwell, A. L. Development of B cell lineages during a primary anti-hapten immune response. J. Immunol. 145, 3216–3222 (1990)
Rada, C., Ehrenstein, M. R., Neuberger, M. S. & Milstein, C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135–141 (1998)
Spencer, J., Dunn, M. & Dunn-Walters, D. K. Characteristics of sequences around individual nucleotide substitutions in IgVH genes suggest different GC and AT mutators. J. Immunol. 162, 6596–6601 (1999)
Bachl, J., Carlson, C., Gray-Schopfer, V., Dessing, M. & Olsson, C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166, 5051–5017 (2001)
Phung, Q. H. et al. Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J. Exp. Med. 187, 1745–1751 (1998)
Reynaud, C. A. et al. Mismatch repair and immunoglobulin gene hypermutation: did we learn something? Immunol. Today 20, 522–527 (1999)
Vora, K. A. et al. Severe attenuation of the B cell immune response in Msh2-deficient mice. J. Exp. Med. 189, 471–481 (1999)
Wiesendanger, M., Kneitz, B., Edelmann, W. & Scharff, M. D. Somatic mutation in MSH3, MSH6, and MSH3/MSH6-deficient mice reveals a role for the MSH2–MSH6 heterodimer in modulating the base substitution pattern. J. Exp. Med. 191, 579–584 (2000)
Zan, H. et al. The translesional polymerase ζ plays a major role in Ig and Bcl-6 somatic mutation. Immunity 14, 643–653 (2001)
Zeng, X. et al. DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nature Immunol. 2, 537–541 (2001)
Rogozin, I. B., Pavlov, Y. I., Bebenek, K., Matsuda, T. & Kunkel, T. A. Somatic mutation hotspots correlate with DNA polymerase η error spectrum. Nature Immunol. 2, 530–536 (2001)
Kobrin, B. J., Casadevall, A., Pirofski, L.-A., Schiff, C. & Scharff, M. D. in Somatic Hypermutation in V Regions (ed. Steele, E. J.) 11–28 (CRC, Boca Raton, 1990)
Kohler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497 (1975)
Sack, S. Z., Bardwell, P. D. & Scharff, M. D. Testing the reverse transcriptase model of somatic mutation. Mol. Immunol. 38, 303–311 (2001)
Acknowledgements
We thank B. Diamond, J. Warner, M. Goodman and R. Laskov for critical review of the manuscript, and A. Bothwell for providing the P1-5 hybridoma. This work was supported by grants from the National Institutes of Health to P.D.B., to C.J.W. and to M.D.S., who is also supported by the Harry Eagle chair provided by the National Women's Division of the Albert Einstein College of Medicine. A.M. is a recipient of Cancer Research Institute and Harry Eagle fellowships.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Martin, A., Bardwell, P., Woo, C. et al. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415, 802–806 (2002). https://doi.org/10.1038/nature714
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature714
This article is cited by
-
A Novel DT40 Antibody Library for the Generation of Monoclonal Antibodies
Virologica Sinica (2019)
-
Diversity of Immunoglobulin (Ig) Isotypes and the Role of Activation-Induced Cytidine Deaminase (AID) in Fish
Molecular Biotechnology (2018)
-
Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells
Nature Methods (2016)
-
Kin17 facilitates multiple double-strand break repair pathways that govern B cell class switching
Scientific Reports (2016)
-
Reproductive traits and mandibular gland pheromone of anarchistic honey bee workers Apis mellifera occurring in China
Apidologie (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.